Introduction
============

Thyroid hormone responsive protein (THRSP) was first described as Spot 14 (*S14*) in rats [@B1]. The authors identified the protein after *in vitro* translation of hepatic RNA treated with different doses of triiodothyronine. THRSP is expressed in liver, mammary gland, white and brown adipose tissue of rats [@B1],[@B2] and located in the nucleus or cytosol [@B3]-[@B5]. In rodents it is suggested to augment the cellular content of lipogenic enzymes like fatty acid synthase in hepatocytes [@B6], [@B7] and in adipocytes [@B8]. Kirschner & Mariash [@B9] found a strong correlation between body mass index in humans and fasting induced downregulation of *THRSP* mRNA. However, a study of Ortega et al. [@B10] suggests that human *THRSP* mRNA amount is inversely associated with obesity. Significant downregulation of *Thrsp* mRNA in response to a 36-hours-fasting period was also observed in rat liver whereas caloric restriction did not influence mRNA abundance [@B11].

Intramuscular fat (IMF) also called marbling is a major determinant of beef quality because of its positive influence on flavor and palatability [@B12]. There are large differences in the ability of different cattle breeds to deposit IMF in *M. longissimus dorsi*(MLD) under similar feeding conditions [@B13]. However, the underlying molecular mechanisms determining fat storage and distribution are widely unknown [@B14]. Consequently, the identification and characterization of candidates for IMF deposition in cattle have been in the focus of numerous studies [@B15]-[@B19]. The gene encoding THRSP was repeatedly named a candidate for different IMF in MLD and an important regulator of adipogenesis and lipogenesis in cattle [@B17], [@B19]-[@B24].

The THRSP gene attracted attention in beef cattle due to its increased mRNA abundance in skeletal muscle of highly marbled crossbred cattle (Wagyu × Hereford) compared to Piedmontese × Hereford cattle with low marbling [@B17]. Higher mRNA abundance of *THRSP* in MLD was also found in our study in F~2~‐bulls (Charolais × Holstein) with high IMF compared to those with low IMF [@B25], [@B26]. Several experiments in cattle indicated that *THRSP* mRNA expression increases with age of the animals and is affected by diet and age of weaning [@B19], [@B27], [@B28]. In all of these studies, *THRSP* mRNA was measured in samples of MLD comprising different amounts of intramuscular fat cells beside other cell types. Consequently, our study aimed at the elucidation of apparent mRNA expression differences of the gene by identification of its cellular origin. Furthermore, we employed western blot analyses and immuno-histochemistry to provide first data on protein amounts and (sub-)cellular localization of THRSP in skeletal muscle tissue of cattle.

Materials and Methods
=====================

Animals and tissue samples
--------------------------

Animal care and tissue collection procedures followed the guidelines of the German Law of Animal Protection and the experimental protocol was approved by our own institutional board (Animal Protection Board of the Leibniz Institute for Farm Animal Biology) as well as by the Animal Care Committee of the State Mecklenburg-Western Pomerania, Germany (State Office for Agriculture, Food Safety and Fishery; LALLF M-V/TSD/7221.3-2.1-010/03).

For this study 20 bulls were selected for either high (7.0 ± 0.6 %, n = 10) or low (1.9 ± 0.6 %, n = 10) IMF content [@B26] from a F~2~-cross of Charolais × Holstein [@B29]. Bulls were kept and fed under standardized conditions and slaughtered at an age of 18 months. Details of sampling and phenotyping were described in [@B30]. Samples of MLD, subcutaneous fat (SCF) and liver were taken, snap-frozen in liquid nitrogen and stored at -80 °C until further processing.

DNA and RNA isolation, cDNA synthesis
-------------------------------------

DNA was extracted from 30 mg liver by phenol/chlorophorm/isopropanol precipitation after proteinase K treatment according to standard procedures. For RNA isolation, SCF was homogenized in QIAzol lysis reagent (Qiagen, Hilden, Germany) with the homogenizer Polytron PT 1200 E (Kinematica, Littau-Luzern, Switzerland) and total RNA was extracted with the RNeasy Lipid Tissue Mini Kit (Qiagen) according to the manufacturer\'s instructions. Muscle tissue was homogenized using the Xiril Dispomix (Xiril, Hombrechtikon, Switzerland) and QIAzol lysis reagent (Qiagen) as described by the manufacturer. The RNA was isolated and purified with NucleoSpin Extract II reagent (Macherey-Nagel, Dueren, Germany) according to manufacturer\'s guidelines. Liver tissue was also homogenized using the Xiril Dispomix. RNA was extracted and purified with the RNeasy Mini Kit (Qiagen) as recommended by the manufacturer. Total RNA was quantified with a NanoDrop ND-1000 spectrophotometer (Peqlab, Erlangen, Germany). The RNA integrity was determined with an Experion Automated Electrophoresis System using the RNA StdSens analysis chip (Bio-Rad, Munich, Germany). First strand cDNA was synthesized from 100 ng total RNA of the respective tissue in 20 µl reaction volume using iScript cDNASynthesis Kit with a blend of oligo(dT) and random hexamer primers (Bio-Rad) according to the provided protocol.

Sampling of muscle and fat cells from MLD by laser capture microdissection (LCM) and cDNA preparation
-----------------------------------------------------------------------------------------------------

Muscle fibers and fat cells were prepared from unstained, dehydrated cross-sections of MLD by LCM as described elsewhere [@B31]. Briefly, 12 µm thick serial cryo-sections of MLD samples were prepared (CM 3050 S, Leica Microsystems, Wetzlar, Germany) of which one was used as control, transferred into a vial with lysis buffer and stored at -80 °C until further processing. Further sections were attached to PALM membrane slides (PALM, Bernried, Germany) and air-dried for 10 s. Dehydration was done by placing the slides in different concentrations of ethanol for 30 s each and in xylene for 5 min. Finally, the slides were air-dried for 5 min under a fume hood. Muscle fibers and adipocytes were sampled separately from these slides using a laser capture microdissection device (MicroBeam, PALM). One hundred to 300 cells per sample and cell type were collected in an adhesive cap of a vial and lysed in RLT buffer (RNeasy Micro Kit, Qiagen). The lysates were stored at -80 °C until further use. Total RNA was extracted separately from lysates of unstained control sections and of both cell types with the RNeasy Micro Kit (Qiagen). Reverse transcription into cDNA was done as described above except that the total amount of isolated RNA was used without prior measurements.

Isolation of primary bovine stromal vascular cells
--------------------------------------------------

SCF was removed from the MLD region of a cow and transported in pre-warmed extraction medium (DMEM/F12 (Sigma-Aldrich, Taufkirchen, Germany) with 15 mM NaHCO~3~ (Carl Roth, Karlsruhe, Germany), 1000 IU/ml penicillin, 1 mg/ml streptomycin, and 25 µm/ml amphotericin B (Biochrom, Berlin, Germany) into the cell laboratory. All subsequent work for cell isolation and cultivation was conducted under strict sterile conditions. First, the adipose tissue was washed with phosphate buffered saline (PBS) with 1000 IU/ml penicillin and 1 mg/ml streptomycin. Visible non-adipose tissue was removed. The SCF was cut into small pieces and transferred into 50 ml centrifuge tubes. To extract the stromal vascular cells from the tissue matrix, an enzymatic digestion was done with a digestion medium (DMEM/F12 with 15 mM NaHCO~3~, 100 mM HEPES (Carl Roth), 1.5 % BSA (Sigma-Aldrich) and 2 mg/ml collagenase I (Biochrom)) for 1 hour at 37 °C in a water bath with continuous shaking. Two ml digestion medium were used per g tissue. After digestion, the suspension was transferred to an Erlenmeyer flask and was diluted with five volumes of post-digestion medium (DMEM/F12 with 15 mM NaHCO~3~, and 100 mM HEPES) and filtered through a 180 µm nylon mesh filter (Merck Millipore, Darmstadt, Germany). The obtained filtrate was then centrifuged at 300 × g for 10 min at 4 °C. The supernatant, consisting of mature adipocytes was discarded. The pellet containing the stromal vascular cells was resuspended with culture medium (DMEM/F12 (PAN-Biotech, Aidenbach, Germany), with 10 % FBS (Thermo Fisher Scientific, Darmstadt, Germany), 100 U/ml penicillin, 100 µg/ml streptomycin, 2.5 µg/ml amphotericin B, and 4 mmol/l glutamine (Biochrom)). The cell suspension was then filtered through a nylon mesh filter with a mesh size of 30 µm (Merck Millipore). This step was followed by a further centrifugation at 300 × g for 10 min at 4 °C. After the pellet was re-suspended in culture medium, the cells were seeded into uncoated 10 mm cell culture dishes (Sarstedt, Nuembrecht, Germany) with a density of about 1 × 10^5^ cells/cm^2^ in culture medium. The cells were cultured under standard conditions (37 °C, 6 % CO~2~, 90 % humidity). After 24 hours, the adherent cells were washed with PBS with 1000 IU/ml penicillin and 1 mg/ml streptomycin and incubated with fresh culture medium. After incubation for 48 or 72 h passaging of the cells was carried out using a trypsin/EDTA solution in PBS (0.05 %/0.02 %, Biochrom). The passaged cells proliferated in culture medium to a confluence of 60-80 % and were then harvested again by using the trypsin/EDTA solution. The cell count and the percentage of viable cells were determined by Invitrogen^TM^ Countess^TM^ automated cell counter (Thermo Fisher Scientific, Braunschweig, Germany). Until further use, the cells were stored in liquid nitrogen in aliquots (1 ml) at a cell count of 0.5-1.0 × 10^6^ cells/ml in freezing medium consisting of culture medium with 30 % FBS and 20 % dimethyl sulfoxide (DMSO, Carl Roth).

Cell culture and RNA preparation
--------------------------------

The murine preadipocyte line 3T3-L1 was purchased from LGC Standards (Wesel, Germany). Cells were seeded into 6-well culture plates (Greiner Bio-One, Frickenhausen, Germany) at a density of 100,000 cells per well and cultivated at 37 °C, 6 % CO~2~ und 90 % humidity in 2 ml proliferation medium (DMEM with 10 % newborn calf serum (NCS), 100 U/ml penicillin, and 100 µg/ml streptomycin (Biochrom)). Medium was changed every 48 hours. Confluence was reached at day 6 and this day was considered as day 0 of differentiation. Differentiation of the cells to mature adipocytes was induced by a medium containing DMEM, 10 % FBS, 100 IU/ml penicillin, 100 µg/ml streptomycin, and 1 µg/ml insulin (Sigma-Aldrich). Medium was exchanged every 48 hours. The differentiation period lasted 19 days. Cells were then either stained with Oil Red O solution or used for extraction of total RNA with the RNeasy Lipid Tissue Mini Kit (Qiagen) as described by the manufacturer.

The bovine stromal vascular cells were thawed, seeded into 6-well culture plates at a cell density of 50,000 cells per well and cultivated under standard conditions in culture medium. The medium was changed every 48 hours. Once the cells had reached their full confluence, various induction or differentiation additives were used to induce the storage of lipids. The induction lasted two days and the differentiation period required 14 days. Here we used and analyzed three different protocols for the differentiation procedure of primary bovine preadipocytes (Table [1](#T1){ref-type="table"}). RNA was extracted at day 0 (start), day 2 and day 12 using the RNeasy Lipid Tissue Mini Kit as recommended by the manufacturer. The results represent the average gene expression measured across the three protocols.

Oil Red O staining
------------------

At days 0 (differentiation start), 2, 7, 14 and 19 of the differentiation process 3T3-L1 cells were stained with Oil Red O. For preparing the Oil Red O stock solution, 0.5 % Oil Red O (Waldeck GmbH & Co. KG, Muenster, Germany) was stirred in isopropanol (Carl Roth) overnight. The fresh Oil Red O working solution was prepared immediately before use. Six parts of the Oil Red O stock solution were mixed with four parts of distilled water, incubated for 10 min and filtered. Cells were washed twice with pre-warmed PBS and fixed with 4 % paraformaldehyde (PFA, Carl Roth) in PBS for 30 min at room temperature. Cells were washed twice with PBS again. Then 60 % isopropanol was added to the cells for 3 min. Subsequently, cells were incubated with fresh Oil Red O working solution for 5 min. Wells were rinsed 3-5 times with distilled water, were covered with gelatin (Waldeck GmbH & Co. KG) and cover slip (Carl Roth) and analyzed with an inverse phase contrast microscope (Nikon Diaphot 300; Nikon, Düsseldorf, Germany), a CC-12 camera (OSIS, Muenster, Germany) and the image analysis software Cell\^F (OSIS).

Analysis of gene expression by Reverse Transcriptase-quantitative PCR (RT-qPCR)
-------------------------------------------------------------------------------

Expression of THRSP, further selected genes and reference genes (Tables [2](#T2){ref-type="table"}) in bovine tissue samples, isolated and cultured cells was analyzed by RT-qPCR (iCycler MyiQ 2 with iQ detection system, Bio-Rad). The gene expression was measured in duplicates for each sample in 10 µl reaction volumes containing 10 ng cDNA, 2 µM of the respective forward and reverse primers and 5 µl SYBR Green Supermix (Bio-Rad). Primers were designed with Primer 3web (Version 4.0.0, <http://primer3.ut.ee/>) and synthesized by Sigma-Aldrich. Primer sequences are given in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}. The amplification comprised an initial denaturation step (95 °C for 3 min) followed by 45 cycles (95 °C for 10 s, 60 °C for 30 s, 70 °C for 45 s). Specificity of the amplicons was confirmed by melting curve analysis and sequencing. Cycle threshold values (C~T~) were determined automatically by iQ5 Software (Version 2.1.97.1001, Bio-Rad). Amplification efficiency was calculated from a standard curve derived from a serial dilution for *B2M* (1:1, 1:20, 1:40, 1:80, 1:100) or from a six point serial dilution for the rest of the genes (1:1, 1:10, 1:20, 1:40, 1:80, 1:160, 1:320). The efficiency E was calculated as E=10 ^-1/slope\ of\ standard\ curve^-1. The expression values obtained in MLD samples were normalized to beta-2-microglobulin (*B2M*) and topoisomerase II beta (*TOP2B*), whereas ubiquitously-expressed transcript (*UXT*) and ribosomal protein S9 (*RPS9*) were used for normalization of expression values obtained in liver. The normalization of expression values from SCF and primary bovine adipocytes was done with *UXT* and *B2M*. Efficiency-corrected, normalized expression values were calculated with the REST algorithm and tested for significant group differences (REST 2009, Version 2.0.13, Qiagen). Results are expressed as fold-changes of the high IMF group to the low IMF group with standard errors as described by [@B32]. Normalization of *THRSP* mRNA abundance to expression of *B2M* and *TOP2B* was done by the NRQ method for subsequent correlation analysis [@B33]. In LCM samples, the mRNA abundance of *THRSP* and marker genes for either muscle fibers (fatty acid binding protein 3, *FABP3*) or adipocytes (fatty acid binding protein 4, *FABP4*) was measured. Due to the low amounts of RNA isolated from dissected cells no reference genes could be analyzed. The data for *THRSP* are given as raw C~T~ values.

In the murine cell line (3T3-L1) the mRNA expression of following genes was measured: protein delta homolog (*Dlk1*), CCAAT/enhancer binding protein beta (*Cebpb*), *Fabp4* and *Thrsp*. The normalization of the expression values was performed with *B2m* and hypoxanthine-guanine phosphoribosyltransferase (*Hprt*). The relative gene expression analyses of the cell line and the primary cells were calculated using the 2^-ΔCt^ method for normalized individual data points recommended by Schmittgen & Livak [@B34].

Partial sequence analysis of the *THRSP* locus
----------------------------------------------

Amplification of genomic DNA fragments was performed with standard PCR and specific primers (Table [4](#T4){ref-type="table"}) in samples of 3 bulls from each group. Putative regulatory regions of the gene (700 bp 5\' of the transcription start and 1,000 bp 3\' of the stop codon containing the 3\'‐untranslated region) were included in screening for single nucleotide polymorphisms (SNPs). After purification of the amplicons with the High Pure PCR Product Purification Kit (Roche Diagnostics, Mannheim, Germany), the PCR products were subjected to cycle sequencing and analyzed on an ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Darmstadt, Germany). The PCR primers were also used for DNA sequencing. Sequences were compared using CLC Main Workbench (v. 7.7, CLCbio, Aarhus, Denmark).

Protein isolation
-----------------

Muscle and liver samples were homogenized with Xiril Dispomix and SCF samples with Polytron PT 1200 E in CelLytic MT lyses reagent and Protease Inhibitor Cocktail (Sigma-Aldrich) to extract total protein according to manufacturer\'s instructions. Tissue lysates were centrifuged at 20817 × g for 15 min to remove insoluble compartments. The supernatant was transferred to a new reaction tube. For separate extraction of nuclear and cytoplasmic proteins of muscle, liver, and SCF the Nuclear/Cytosol Fractionation Kit (Promokine, Heidelberg, Germany) was used. First, tissues were homogenized in PBS and Protease Inhibitor Cocktail (Sigma-Aldrich) as described before. Protein fractions were obtained following the manufacturer\'s protocol. Protein amounts were measured using a Nanodrop ND-1000 spectrophotometer (Peqlab, VWR, Erlangen, Germany). Protein extracts and fractions were stored at -80 °C until further use.

Western blot
------------

A custom made antibody against a 16 amino acids synthetic peptide representing the C-terminal part of bovine THRSP (Pierce Custom Antibody Service, Thermo Scientific) was used for detection of THRSP in bovine tissues. Antibodies against MLXIPL (LS-C31701) and MID1IP1 (LS-C139634) were purchased from Biozol (Eching, Germany). Twenty micrograms of extracted protein were diluted in Laemmli buffer with ß-mercaptoethanol, denatured at 95 °C for 5 min, and separated on Criterion TGX 12 % gels (Bio-Rad). A molecular weight marker (Page Ruler, Thermo Scientific) was separated simultaneously for determination of the molecular weight of the detected protein bands. Proteins were transferred to a polyvinylidene difluoride (PVDF) membrane (Trans-Blot Turbo transfer pack, Bio-Rad) using a semi dry blotter (Trans-Blot, Bio-Rad). Additionally, 15 % SDS-PAGE 10 × 10 cm mini gels were used and blotted on PVDF membranes (Carl Roth) for tests of specificity of antibody binding. Equal loading of the gels and proper transfer of the proteins to the membranes were verified by Coomassie staining according to standard procedures. Membranes were blocked for 1 h in either 1× Roti-Block (Carl Roth), for detection of THRSP, or 5 % non-fat dry milk (Carl Roth) in Tris-buffered saline (TBS), for detection of MLXIPL and MID1IP1. Membranes were incubated with primary antibodies (THRSP diluted 1:500, MLXIPL and MID1IP1 diluted 1:2,000) over night at 4 °C. The specificity of THRSP antibody binding was tested against recombinant protein (CSB-EP726789MO, Biotrend, Cologne, Germany) and using parallel blots, which were incubated with either the antibody or with the antibody blocked with the antigen peptide prior to incubation. Membranes were incubated with Horseradish peroxidase-conjugated secondary antibody (rabbit IgG TrueBlot, 1:25,000; 18-8,816, eBioscience, Frankfurt, Germany) and the antibody label was detected with chemiluminescence substrate (SuperSignal West Femto Substrat, Thermo Scientific). Unspecific binding of the secondary antibody was excluded by incubating negative controls in PBS-T containing 2 % goat serum instead of primary antibody. A Chemocam HR-16 imager (INTAS, Göttingen, Germany) equipped with LabImage 1D software (Kapelan Bio-Imaging, Leipzig, Germany) were used to record and quantify intensity of specific bands.

Immuno-histochemical and -cytochemical analysis
-----------------------------------------------

Immuno-fluorescent staining was performed in bovine tissue sections and the murine cell line 3T3-L1. Different bovine tissues were cryo-sectioned with a thickness of 10 µm (liver), 12 µm (MLD) and 25 µm (SCF) using a CM3050 S cryostat microtome (Leica). Sections were air dried for 15 min and fixed with 4 % PFA in PBS. The 3T3-L1 cells were washed two times with PBS before fixation with 4 % PFA in PBS. After washing with PBS, liver sections were incubated with filtrated Sudan Black (0.1 % in 70 % ethanol, Waldeck GmbH & Co. KG) for 30 min and washed twice with PBS. Fat was extracted from SCF sections by gently shaking the slide in chloroform (Carl Roth) for 5 min. Afterwards, permeabilization with PBS-TritonX100 (PBST) was performed for 10 min in all tissue sections and the 3T3-L1 cells. Unspecific binding of the secondary antibody was blocked using 10 % goat serum in PBST for 15 min. Incubation with the bovine specific polyclonal antibody rabbit anti-THRSP8816 (1:300, Pierce Custom Antibody Service) was done for 2 h at room temperature in a humidity chamber. Slides and wells were washed 3 times with PBST. Specific binding of primary antibody was detected with the respective Alexa Fluor 488 goat anti-rabbit IgG secondary antibody (MoBiTec, Goettingen, Germany, 1:1,000 in PBST). Then, slides and wells were washed with PBST 3 times for 10 min. Nuclei were counterstained with Hoechst 33258 (Sigma-Aldrich, 1:10,000 in PBST). Finally, slides and wells were washed twice with PBS for 5 min and 5 min with distilled water and subsequently covered using ProLong Diamond Antifade Mountant (Thermo Scientific) and appropriate cover-slips. Immuno-fluorescence was visualized with a Nikon Microphot SA fluorescence microscope (Nikon) and an image analysis system equipped with CELL\^F software and a CC- 12 high resolution color camera (OSIS).

Statistical analyses
--------------------

The statistical analyses for the evaluation of the mRNA expression results obtained by RT-qPCR are described in respective paragraphs. For analyses of normalized protein abundances, the MIXED procedure of SAS (Version 9.2, 2009, SAS Inst. Inc., Cary, USA) was used with the fixed factor IMF group, separately for each tissue, and the repeated factor blot to account for repeated measures of each sample. For post-hoc tests the Tukey-Kramer-correction was used. The presented values are LSMEANs with SE. Relationships between traits were calculated as Pearson correlation coefficients with SAS.

Results
=======

*THRSP* mRNA is increased in muscle of highly marbled cattle at 18 months of age
--------------------------------------------------------------------------------

An initial analysis confirmed a significantly higher expression of *THRSP* in MLD of bulls with high IMF compared to those with low IMF (Figure [1](#F1){ref-type="fig"}; Fold change \[FC\] = 1.7, p \< 0.05). In contrast to results in muscle, expression in liver and subcutaneous fat was not different between both groups (Figure [1](#F1){ref-type="fig"}).

The normalized mRNA abundance of *THRSP* in MLD was significantly correlated with the IMF content (r = 0.47; p \< 0.05).

Next, we measured the expression of a potential regulator of THRSP - carbohydrate-responsive element-binding protein (*MLXIPL*). This gene was not or only weakly detectable in muscle samples making a comparison between both groups impossible. *MLXIPL1* was stronger expressed in SCF, but no differences were observed between both groups (1.15-fold, p = 0.21). MID1 interacting protein 1 (*MID1IP1*) is putatively interacting with THRSP. However, its mRNA abundance did neither differ in MLD samples of both groups (1.0-fold, p = 0.98) nor in SCF (1.19-fold, p = 0.29). To account for potential effects of microRNAs (miRNAs) on gene expression, we analyzed respective data from an array analysis (unpublished data). A total of 66 miRNAs were predicted by TargetScan 7.1 [@B35] to bind to the 3\' - UTR of bovine *THRSP*. None of the miRNAs were differentially expressed in MLD of our sample (q \> 0.10, data not shown).

No single nucleotide polymorphisms (SNPs) in putative regulatory sequences of the bovine *THRSP* locus
------------------------------------------------------------------------------------------------------

We screened the bovine *THRSP* locus for SNPs with focus on regions with potential effect on gene expression. Besides the complete coding region, 700 base pairs (bp) 5\' of the transcription start and 1,000 bp 3\' of the stop codon were included. An overview about the structure of the locus is given in Figure [2](#F2){ref-type="fig"}.

We identified three SNPs in our sample. Two SNPs, c.88G\>A and c.194C\>T, have been described before, whereas SNP c.\*695T\>C in the 3\' untranslated region (3\'-UTR) of *THRSP* is novel. However, this polymorphism segregates only in one family of the investigated F~2~-population. None of the SNPs was found in motifs with potential effects on gene expression like promotor or miR-binding sites. In addition, *in silico*-analyses showed that putative upstream regulatory elements described for the human and rat genes are not conserved in cattle.

*THRSP* is mainly expressed in adipocytes in bovine skeletal muscle tissue
--------------------------------------------------------------------------

Our analyses did not reveal any structural alteration at the bovine *THRSP* locus explaining the observed increased expression in MLD of highly marbled cattle. Therefore, we set out to clarify whether the increased amount of *THRSP* mRNA in skeletal muscle of bulls with higher IMF was caused by the larger number of adipocytes in the sample. We dissected bovine skeletal muscle tissue by laser capture microdissection (LCM, Figure [3](#F3){ref-type="fig"} a, b) and analyzed the expression of *THRSP* in adipocytes and muscle cells separately. The expression of *FABP3* and *FABP4* was used as indicator for the purity of the cell preparations. As expected, *FABP4* was exclusively expressed in adipocytes whereas *FABP3* expression was restricted to muscle cells. *THRSP* expression was observed in adipocytes but not in myocytes in three independent experiments (Table [5](#T5){ref-type="table"}).

*THRSP* protein is predominantly located in nuclei
--------------------------------------------------

Serial sections were prepared from samples used for LCM (Figure [3](#F3){ref-type="fig"} a, b) for detection of THRSP in MLD by immuno-histochemistry. Specific fluorescence signals were detected in nuclei of adipocytes and in nuclei of adipose tissue associated cells which were not further characterized (data not shown). In accordance with results from LCM experiments THRSP was not detected in myocytes.

Additional immuno-histochemical investigations were done in sections of bovine SCF, liver, and MLD. THRSP was abundantly detected in nuclei of subcutaneous adipocytes and in nuclei of cells of the interstitium (Figure [4](#F4){ref-type="fig"} a). In liver samples expression of THRSP was restricted to nuclei of cells of the portal triad (Figure [4](#F4){ref-type="fig"} c) whereas in skeletal muscle cells other than myocytes were stained exclusively (Figure [4](#F4){ref-type="fig"} e). The corresponding stainings of nuclei in the tissues are given in figure [4](#F4){ref-type="fig"} b, d, and f.

Since the protein amount of THRSP in total protein extracts from liver and MLD was below the detection limit of western blot and our results of immuno-histochemical analysis strongly suggested a nuclear localization of THRSP protein, we hence extracted proteins from nuclear and cytoplasmic fractions separately. As expected, THRSP could be detected exclusively in the nuclear fractions of all tissues. Representative blots for liver and SCF are shown in figure [5](#F5){ref-type="fig"}. The signals were strongest in SCF and weak in liver and MLD. This is in accordance with the results from the immuno-histochemical examination.

The protein amount of THRSP was analyzed by semi-quantitative western blots of total protein from SCF and of nuclear fractions from liver and MLD. In none of the tissues significant differences in THRSP protein amounts were found between cattle with high or low intramuscular fat deposition (Figure [6](#F6){ref-type="fig"}).

*THRSP* is expressed late during adipogenic differentiation
-----------------------------------------------------------

We then analyzed mRNA abundance during differentiation of 3T3-L1 cells to get insight into the ontogenetic course of *Thrsp* expression (Figure [7](#F7){ref-type="fig"}). Cells were harvested at days 0, 2, 7, 14, and 19 of differentiation. Besides *Thrsp,* several established markers were co-analyzed. *Dlk1*, also known as preadipocyte factor 1, was typically down-regulated in the course of differentiation. *Cebpb* represents an early marker of fat cell differentiation and was expressed constantly during the differentiation process. This indicated that differentiating preadipocytes were still present in culture at all stages. The expression of *Fabp4* was only detectable when lipid droplets became visible in the cells.

The mRNA abundance of *Thrsp* followed the pattern observed for *Fabp4* indicating that only differentiated adipocytes express this factor. Of note, *Thrsp* is a very low abundance transcript compared to the markers used in this study.

Immuno-cytochemical analyses of cultured 3T3-L1 cells at days 2 and 21 after start of differentiation confirmed the localization of Dlk1 in cytoplasm of adipocytes without visible lipid accumulation at both time points and nuclear signals for Cebpb in small adipocytes with beginning lipid accumulation but revealed no results for Thrsp at day 21 (data not shown).

The expression of *THRSP*, *FABP4*, and *CEBPB* was also measured in bovine primary stromal vascular cells on day 0 (start), day 2 and day 12 of differentiation (Figure [8](#F8){ref-type="fig"}). The expression patterns of *THRSP* and *FABP4* were similar to those in the murine cell line. *THRSP* was even lower expressed than in 3T3-L1 cells. In contrast to the murine cell line the mRNA concentration of *CEBPB* declined markedly with progression of differentiation of bovine adipocytes.

Discussion
==========

The search for markers and predictors of intramuscular fat content in cattle muscle is of economic importance since it influences profitability of beef production [@B19]. Consequently, numerous studies aimed at the identification and characterization of putative candidate genes for those markers. Breeds with extreme differences in IMF were investigated (e.g. [@B36], [@B37] as well as crosses using those breeds [@B17]). Highly different expressions of *THRSP* and further genes related to lipid metabolism were frequently found in these investigations. Later bioinformatics approaches named THRSP as a top candidate related to IMF [@B19], [@B38]. However, Hudson et al. [@B19] stated a surprisingly late divergence of the expression of *THRSP* and further genes between high and low marbled breeds at 20 months of age and later. We observed a significantly increased *THRSP* expression in MLD of bulls with high IMF compared to those with low IMF within a cross between Charolais and Holstein at 18 months of age [@B25], [@B26]. It was the first time that differences in *THRSP* mRNA abundance in MLD were found in a population with the same genetic background and not between breeds or between breed crosses. However, we found no expression differences in other tissues like liver and SCF in this study indicating that there is no systemic difference in the activity of THRSP between bulls with high and low IMF. Against this background, we set out to elucidate the apparent expression differences of *THRSP* between highly and lowly marbled muscles.

DNA sequence analysis revealed no differences at the *THRSP* locus which could explain expression differences between both groups by cis-regulatory elements. Two coding SNPs with known association to milk fat, fatty acid composition and water binding capacity of beef [@B39]-[@B43] and a newly identified SNP segregate in our F~2~-population but were not associated to IMF [@B44]. Furthermore, no SNPs in putative regulatory sequences at the *THRSP* locus were found. Abundance of microRNA with THRSP as potential target was also not different between groups (unpublished data). Collectively, this indicates no differential cis regulation of the expression of *THRSP* in our sample.

We demonstrated that *THRSP* mRNA is only detectable in adipocytes and interstitial cells of skeletal muscle. Thus, most likely the mRNA abundance of *THRSP* is related to the number of adipocytes and associated cells in the MLD sample rather than to genuine expression differences of the gene. Support for this assumption comes from an earlier investigation of dissected IMF from highly marbled Japanese Black steers and Holstein steers with lower marbling under identical feeding regimen. No differences in *THRSP* expression were found in dissected IMF despite large differences in IMF content of the MLD [@B45]. The positive correlation between IMF content of the MLD samples and mRNA abundance of *THRSP* in our study provides further evidence for a similar *THRSP* expression in mature intramuscular adipocytes regardless whether they are located in highly or lowly marbled MLD of cattle.

Data on THRSP protein were only available for rodent liver, cell lines, and human adipocytes so far (e.g. [@B10], [@B46], [@B47]). We demonstrated a mainly nuclear localization of THRSP protein in mature bovine adipocytes, in undetermined adipose-associated cells and in specific regions of liver by immuno-histochemistry and western blot of subcellular fractions with an antibody against bovine THRSP. The nuclear localization is in accordance with the proposed function of THRSP as transcriptional regulator [@B5], [@B22]-[@B24], [@B48]. It must be noted however, that THRSP seems not to be a transcription factor because the protein contains no recognized DNA-binding motifs. Therefore, THRSP is referred to as transcriptional co-activator or, more general as transcriptional regulator with unknown function [@B48]. Provided that THRSP is active in transcriptional regulation, its direct effects should be restricted to the cells where it is expressed. A higher apparent THRSP expression in a heterogeneous tissue like skeletal muscle is consequently linked with a higher number of THRSP expressing cells (mostly adipocytes) rather than with a higher expression within a cell. No differences in THRSP protein amounts were found in the nuclear fraction of MLD samples with different IMF content. This is in contrast to the results at mRNA level and might be caused by the lower sensitivity of western blotting compared to RT-qPCR. Moreover, posttranslational cleavage of mRNA may have contributed to this result.

The polyclonal antibody against bovine THRSP reacted consistently with a protein of \~37 kDa in bovine tissues. Specificity of the detected band could be shown by its disappearance after pre-incubation of the antibody with recombinant THRSP. However, the predicted molecular weight of bovine THRSP is roughly 17 kDa and thus much smaller than the observed immuno-reactive band. The most likely explanation is that THRSP exists as homodimer. This property of THRSP was described already by Cunningham et al. [@B48]. The authors found THRSP to form homodimers in mammalian cells and suggested the formation of a tripartite complex with an unknown 36 kDa protein for its full regulatory activity.

In liver, THRSP protein was mainly found in nuclei of cells in the periportal triads. A localization of THRSP in specific liver zones where lipogenic enzymes are active was described for the rat before [@B5]. Although, these authors observed a perivenous rather than a periportal localization of THRSP in rat liver, some lipogenic enzymes were assigned to the periportal triads by another group [@B49]. Consequently, our data support a role of THRSP as transcriptional regulator of lipogenic enzymes in bovine liver.

It is well-known that THRSP is regulated by hormonal and dietary intervention in rat tissues [@B5], [@B50]. Numerous investigations in dairy and beef cattle have shown that dietary components like fatty acids, carbohydrates and excess energy affect the expression of *THRSP* in mammary epithelium, adipose, liver, and muscle [@B21], [@B23], [@B27], [@B51]. Notably, the IMF content of the MLD - estimated as marbling score - was not significantly different in two of those experiments conducted in beef cattle [@B21], [@B27]. Dietary intervention (high starch vs. low starch diet) resulted in opposite effects on *THRSP* mRNA abundance in both studies, however. A compensatory physiological mechanism was suggested as possible explanation for a higher expression of *THRSP* in low-starch fed animals of the second study [@B27]. In a recent investigation, significant down-regulation of *THRSP* was found in steers with a low estimated genomic breeding value for iron content of the meat compared to those with a high one [@B52]. The authors assumed a reduced lipogenic activity in muscle with lower iron content. However, the IMF content differed only slightly between both groups of animals (low iron: 2.9 % vs. high: 2.3 %) contradicting this notion.

Conclusion
==========

Our study in cattle without intervention demonstrated that *THRSP* was not regulated by cis-elements close to the gene and the apparently increased *THRSP* mRNA abundance was presumably a function of an increasing number of intramuscular adipocytes. This was supported by immuno-histochemical detection of THRSP exclusively in adipocytes and related cells. Since intramuscular adipocytes are not evenly distributed in MLD, composition of small samples may be affected by differing numbers of included adipocytes.

In summary, our results indicate that a high expression of *THRSP* in skeletal muscle reflects the result of an increased intramuscular adipogenesis, is not involved in the early events, and is consequently not a reason of varying IMF content in MLD of cattle. The localization of THRSP mRNA and protein in nuclei of adipocytes provides experimental support for the suggested role of THRSP in transcriptional regulation of lipid metabolism.
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BSA

:   bovine serum albumin

IMF

:   intramuscular fat

LCM

:   laser capture microdissection

MLD

:   Musculus longissimus dorsi

PBS

:   phosphate buffered saline

PBST

:   PBS-TritonX100

PFA

:   paraformaldehyde

SCF

:   subcutaneous fat.

![**mRNA-expression of *THRSP* in different bovine tissues**(n = 10 per group) Expression was normalized to *UXT* and *B2M* (subcutaneous fat (SCF)), *UXT* and *RPS9*(liver), and *B2M* and *TOP2B*(M. longissimus dorsi (MLD)). Graphs show group means (duplicate measurements) with standard errors calculated by REST software [@B32].](ijbsv13p0532g001){#F1}

![**Structure of the bovine *THRSP* locus** Primer positions are marked by arrows. Exons are given as grey boxes, introns and intergenic sequences are white. Numbers refer to nucleotide positions relative to the start of the mRNA. Single nucleotide polymorphisms are marked above the graph.](ijbsv13p0532g002){#F2}

![**Sections of M. longissimus dorsi (MLD) used for laser capture microdissection (LCM)** Adipocytes (a) and myocytes (b) were marked (green lines) and sampled by LCM.](ijbsv13p0532g003){#F3}

![**Cellular localization of THRSP in bovine tissues** Immuno-histochemical localization of THRSP was performed in cross-sections of subcutaneous fat (SCF) (a), liver (c) and M. longissimus dorsi (MLD) (e). THRSP was detected with a specific bovine antibody and the secondary antibody Alexa Fluor® 488 goat anti-rabbit IgG. It was found in the nuclei of fat cells, interstitial cells and cells of the portal triad. Identical images of each tissue presented with nuclear staining permit a direct comparison (b, d, f). The yellow arrows point to THRSP located in nuclei and adipocytes without THRSP signal are marked by a yellow box.](ijbsv13p0532g004){#F4}

![**Western blot with fractionated proteins of bovine liver and subcutaneous fat (SCF)** THRSP could be detected in the nuclear (NF) but not cytoplasmic (CF) fraction of liver and SCF. THRSP could also be detected in the total protein extract (TP) from SCF. MW - molecular weight marker.](ijbsv13p0532g005){#F5}

![**THRSP protein expression in different bovine tissues of F~2~-bulls**(n = 10 per group) Representative protein bands from the total protein fraction of subcutaneous fat (SCF) (a). The dilution of the antibody was 1:500. Comparison of THRSP protein amount in bovine tissues from bulls with high and low intramuscular fat content (IMF-content) in M. longissimus dorsi (MLD) (b). H - high IMF-content, L - low IMF-content, NF - nuclear fraction, TP - total protein](ijbsv13p0532g006){#F6}

![**(a) Oil Red O staining of 3T3-L1 cells at different time points of the differentiation to mature adipocytes. (b) Relative mRNA expression of different genes in 3T3-L1 cells.** The expression values of the target genes (duplicate analyses) were normalized with *B2m* and *Hpr*t. The analysis and the comparison of the relative gene expression were conducted with the 2^-ΔCt^ method for normalized individual data points recommended by Schmittgen & Livak [@B34].](ijbsv13p0532g007){#F7}

![**Relative mRNA expression of different genes in bovine primary stromal vascular cells**(n = 3 per time point) The expression of target genes was normalized to *B2M* and *UXT*. The analysis and the comparison of relative gene expression was done as described by Schmittgen & Livak [@B34].](ijbsv13p0532g008){#F8}

###### 

Protocols for the induction and differentiation of primary bovine stromal vascular cells

  ------------------------------------------------------------------------------------------------------------
  Protocol                 1                           2                           3
  ------------------------ --------------------------- --------------------------- ---------------------------
  Induction medium         DMEM/F12\                   DMEM/F12\                   DMEM/F12\
                           100 IU/ml penicillin\       100 IU/ml penicillin\       100 IU/ml penicillin\
                           100 µg/ml streptomycin\     100 µg/ml streptomycin\     100 µg/ml streptomycin\
                           2.5 µg/ml amphotericin B\   2.5 µg/ml amphotericin B\   2.5 µg/ml amphotericin B\
                           4 mmol/l glutamine\         4 mmol/l glutamine\         4 mmol/l glutamine\
                           2.5 µg/ml insulin\          5 µg/ml insulin\            5 µg/ml insulin\
                           0.25 µM Dexamethasone       0.25 µM dexamethasone       150 µM oleic acid\
                                                                                   0.25 µM dexamethasone

  Differentiation medium   DMEM/F12\                   DMEM/F12\                   DMEM/F12\
                           100 IU/ml penicillin\       100 IU/ml penicillin\       100 IU/ml penicillin\
                           100 µg/ml streptomycin\     100 µg/ml streptomycin\     100 µg/ml streptomycin\
                           2.5 µg/ml amphotericin B\   2.5 µg/ml amphotericin B\   2.5 µg/ml amphotericin B\
                           4 mmol/l glutamine\         4 mmol/l glutamine\         4 mmol/l glutamine\
                           2.5 µg/ml insulin           5 µg/ml insulin             5 µg/ml insulin\
                                                                                   150 µM oleic acid
  ------------------------------------------------------------------------------------------------------------

###### 

Primer sequences for RT-qPCR with bovine cDNA

  Gene        Sequence (5\'→3\') forward   Sequence (5\'→3\') reverse   GenBank acc. no.   Product size (bp)
  ----------- ---------------------------- ---------------------------- ------------------ -------------------
  *B2M*       CAGCTGCTGCAAGGATGG           ATTTCAATCTGGGGTGGATG         NM_173893          184
  *FABP3*     GCGTTCTCTGTCGTCTTTCC         CTTGGTCATATTGCCCACCT         NM_174313          154
  *FABP4*     GGATGGAAAATCAACCACCA         TGGACAACGTATCCAGCAGA         NM_174314.2        174
  *MID1IP1*   CAGTTGCCCCGTCCTAAGTA         GATAGAGGTGCCACAGGACA         NM_001076383.1     157
  *MLXIPL*    CATCACACACATCTCTGCGG         GCACAGGTTAATGGCAGCAT         NM_001205408.1     241
  *RPS9*      GCTGATCGGCGAGTATGGGCT        GCCGCCGCAACAGGGCATTA         NM_001101152       152
  *THRSP*     GAGATGGAAGAGGCTGAGGA         CAGGGTAAGATGGGTGAGGA         NM_001040533       108
  *TOP2B*     AAGAAAACAGCACCGAAAGG         GAGGTCTGAGGGGAAGAGGT         XM_002698750       174
  *UXT*       TCATGGCGACGCCCCCTAAAC        AAAGCCTCGTAGCGCAGCACT        NM_001037471       70

###### 

Primer sequences for RT-qPCR with murine cDNA

  Gene      Sequence (5\'→3\') forward   Sequence (5\'→3\') reverse   GenBank acc. no.   Product size (bp)
  --------- ---------------------------- ---------------------------- ------------------ -------------------
  *B2m*     CCTGGTCTTTCTGGTGCTTG         TTTCCCGTTCTTCAGCATTT         NM_009735          175
  *Cebpb*   TGCGGGGTTGTTGATGTTTT         TGCTCGAAACGGAAAAGGTT         NM_001287739.1     156
  *Dlk1*    AGTATGGATTCTGCGAGGCT         GCAAGCCCGAACGTCTATTT         NR_033813.1        179
  *Fabp4*   TTTCCTTCAAACTGGGCGTG         CATTCCACCACCAGCTTGTC         NM_024406.2        166
  *Hprt*    TCCTCCTCAGACCGCTTTT          CCTGGTTCATCATCGCTAATC        NM_013556          90
  *Thrsp*   TACCAGGAAATGACAGGGCA         TGCAACCAAGTCCACAGATG         NM_009381.2        183

###### 

Primer sequences for the amplification and sequencing of regions of the *THRSP* locus

  Primer          Sequence (5\'→3\') forward   Primer          Sequence (5\'→3\') reverse   Product size (bp)
  --------------- ---------------------------- --------------- ---------------------------- -------------------
  THRSP_F1_Ex1    ATCCTGTCAAACTGCTGTGC         THRSP_R1_Ex1    ATCATCACCACCTGCTCCAT         195
  THRSP_F2_Ex1    GTGGTGATGATCCCCAGTCT         THRSP_R2_Ex1    TTCCTGGGTTGTGGTCTCAA         509
  THRSP_F1_Ex1    ATCCTGTCAAACTGCTGTGC         THRSP_R3_Ex1    CTTCAGTCTCAGCTCCCTCG         383
  THRSP_F3_vEx1   AGTGGGCAGCTTGGTCTTAG         THRSP_R1_Ex1    ATCATCACCACCTGCTCCAT         475
  THRSP_F4_vEx1   ACTGGAGGTGAGAGAGAGGT         THRSP_R4_vEx1   CTAAGACCAAGCTGCCCACT         387
  THRSP_F5_Ex2    TTTTGCAGCTCTGACAACCA         THRSP_R5_Ex2    GACGAGGAAATTTAGGCCACA        550
  THRSP_F6_Ex2    AACAGTAAGTCAAAAGCATCTGG      THRSP_R6_Ex2    AAGATCCCACACAACTAGAATGA      491

###### 

Expression of *THRSP* and cell type markers in dissected adipocytes and myocytes from bovine M. longissimus dorsi (MLD)

  Genes   Cell type   
  ------- ----------- -----------
  FABP3   ND          26.9±0.99
  FABP4   20.4±1.04   ND
  THRSP   26.6±0.66   ND

(C~T~ values obtained by RT-qPCR, n =3, means ± standard deviations)

ND - not detected
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